Cargando…

Suppression of KSHV lytic replication and primary effusion lymphoma by selective RNF5 inhibition

Primary effusion lymphoma (PEL), a rare aggressive B-cell lymphoma in immunosuppressed patients, is etiologically associated with oncogenic γ-herpesvirus infection. Chemotherapy is commonly used to treat PEL but usually results in poor prognosis and survival; thus, novel therapies and drug developme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xiaojuan, Wang, Fan, Zhang, Xiaolin, Sun, Qinqin, Kuang, Ersheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9888681/ https://www.ncbi.nlm.nih.gov/pubmed/36656913 http://dx.doi.org/10.1371/journal.ppat.1011103

Ejemplares similares

RSK-c-Fos in KSHV lytic progression
por: Li, Xiaojuan, et al.
Publicado: (2015)

Targeting FoxO proteins induces lytic reactivation of KSHV for treating herpesviral primary effusion lymphoma
por: Lan, Jungang, et al.
Publicado: (2023)

RSK1 SUMOylation is required for KSHV lytic replication
por: Liu, Zhenshan, et al.
Publicado: (2021)

Downregulation of EphA2 stability by RNF5 limits its tumor-suppressive function in HER2-negative breast cancers
por: Li, Xiaojuan, et al.
Publicado: (2023)

KSHV Targeted Therapy: An Update on Inhibitors of Viral Lytic Replication
por: Coen, Natacha, et al.
Publicado: (2014)

Productive herpesvirus lytic replication in primary effusion lymphoma cells requires S-phase entry
por: Hollingworth, Robert, et al.
Publicado: (2020)

Molecular mechanisms of activating c-MET in KSHV+ primary effusion lymphoma
por: Lam, Bao Quoc, et al.
Publicado: (2017)

Activation of DNA Damage Response Pathways during Lytic Replication of KSHV
por: Hollingworth, Robert, et al.
Publicado: (2015)

KSHV activates unfolded protein response sensors but suppresses downstream transcriptional responses to support lytic replication
por: Johnston, Benjamin P., et al.
Publicado: (2019)

Genomic analysis of xCT-regulatory network in KSHV + primary effusion lymphomas
por: Qin, Zhiqiang, et al.
Publicado: (2016)

Targeting Myc in KSHV-associated primary effusion lymphoma with BET bromodomain inhibitors
por: Tolani, Bhairavi, et al.
Publicado: (2013)

Cell Type-Specific Interferon-γ-mediated Antagonism of KSHV Lytic Replication
por: Park, Mi-Kyung, et al.
Publicado: (2019)

Molecular Biology of KSHV Lytic Reactivation
por: Purushothaman, Pravinkumar, et al.
Publicado: (2015)

Regulation of KSHV Latency and Lytic Reactivation
por: Broussard, Grant, et al.
Publicado: (2020)

Systematic Analysis of a Xenograft Mice Model for KSHV(+) Primary Effusion Lymphoma (PEL)
por: Dai, Lu, et al.
Publicado: (2014)

Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi’s Sarcoma-Associated Herpesvirus Latent and Lytic Replications
por: Gruffaz, Marion, et al.
Publicado: (2018)

The SUMO E3 ligase activity of ORF45 determines KSHV lytic replication
por: Liu, Zhenshan, et al.
Publicado: (2022)

Epigenetic Analysis of KSHV Latent and Lytic Genomes
por: Toth, Zsolt, et al.
Publicado: (2010)

Contribution of the KSHV and EBV lytic cycles to tumourigenesis
por: Manners, Oliver, et al.
Publicado: (2018)

Extracavitary KSHV-positive Solid Lymphoma: A Large B-cell Lymphoma Within the Spectrum of Primary Effusion Lymphoma
por: Carbone, Antonino, et al.
Publicado: (2013)

Reticulophagy Reprograms the Endoplasmic Reticulum for SARS-CoV-2 Replication
por: Li, Xiaojuan, et al.
Publicado: (2022)

Hsp90 is a viable therapeutic target in the treatment of KSHV-associated primary effusion lymphoma
por: Nayar, Utthara, et al.
Publicado: (2010)

K13 Blocks KSHV Lytic Replication and Deregulates vIL6 and hIL6 Expression: A Model of Lytic Replication Induced Clonal Selection in Viral Oncogenesis
por: Zhao, Jinshun, et al.
Publicado: (2007)

m(6)A Regulates the Stability of Cellular Transcripts Required for Efficient KSHV Lytic Replication
por: Manners, Oliver, et al.
Publicado: (2023)

Capsaicin Induces Apoptosis in KSHV-Positive Primary Effusion Lymphoma by Suppressing ERK and p38 MAPK Signaling and IL-6 Expression
por: Moriguchi, Misato, et al.
Publicado: (2019)

The cellular and KSHV A-to-I RNA editome in primary effusion lymphoma and its role in the viral lifecycle
por: Rajendren, Suba, et al.
Publicado: (2023)

Mutual Inhibition between Kaposi's Sarcoma-Associated Herpesvirus and Epstein-Barr Virus Lytic Replication Initiators in Dually-Infected Primary Effusion Lymphoma
por: Jiang, Yanjun, et al.
Publicado: (2008)

NDRG1 facilitates lytic replication of Kaposi’s sarcoma-associated herpesvirus by maintaining the stability of the KSHV helicase
por: Dong, Lianghui, et al.
Publicado: (2021)

Targeting KSHV/HHV-8 Latency with COX-2 Selective Inhibitor Nimesulide: A Potential Chemotherapeutic Modality for Primary Effusion Lymphoma
por: George Paul, Arun, et al.
Publicado: (2011)

Human IFIT proteins inhibit lytic replication of KSHV: A new feed-forward loop in the innate immune system
por: Li, Dajiang, et al.
Publicado: (2019)

SARS-CoV-2 Nsp8 suppresses MDA5 antiviral immune responses by impairing TRIM4-mediated K63-linked polyubiquitination
por: Zhang, Xiaolin, et al.
Publicado: (2023)

Epigenetic factor siRNA screen during primary KSHV infection identifies novel host restriction factors for the lytic cycle of KSHV
por: Naik, Nenavath Gopal, et al.
Publicado: (2020)

SUMO and KSHV Replication
por: Chang, Pei-Ching, et al.
Publicado: (2014)

Combination of Arsenic and Interferon-α Inhibits Expression of KSHV Latent Transcripts and Synergistically Improves Survival of Mice with Primary Effusion Lymphomas
por: El Hajj, Hiba, et al.
Publicado: (2013)

The activation of KSHV lytic cycle blocks autophagy in PEL cells
por: Granato, Marisa, et al.
Publicado: (2015)

The landscape of transcription initiation across latent and lytic KSHV genomes
por: Ye, Xiang, et al.
Publicado: (2019)

Phosphoproteomic Analysis of KSHV-Infected Cells Reveals Roles of ORF45-Activated RSK during Lytic Replication
por: Avey, Denis, et al.
Publicado: (2015)

Identification of Mubritinib (TAK 165) as an inhibitor of KSHV driven primary effusion lymphoma via disruption of mitochondrial OXPHOS metabolism
por: Calderon, Abram, et al.
Publicado: (2020)

iTIME.219: An Immortalized KSHV Infected Endothelial Cell Line Inducible by a KSHV-Specific Stimulus to Transition From Latency to Lytic Replication and Infectious Virus Release
por: Dollery, Stephen J., et al.
Publicado: (2021)

Dysregulation of the miR‐30c/DLL4 axis by circHIPK3 is essential for KSHV lytic replication
por: Harper, Katherine L, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rsb87q0lrfjdch5clcdbr66gj0